| | | |

Study Questions Diaphragm Resection in Mesothelioma Surgery

9171649_woman patient3Is it always necessary to remove a portion of the diaphragm when performing radical mesothelioma surgery? A team of researchers in the UK and Italy don’t think so.

They have just published their assessment of 314 pleural mesothelioma patients who underwent surgery for their disease to see how critical a role the diaphragm appeared to play in their recovery.

According to the team’s findings, including the diaphragm in mesothelioma surgery may not have a significant impact on mesothelioma survival.

Surgical Management of Pleural Mesothelioma

Extrapleural pneumonectomy (EPP) is the most radical form of pleural mesothelioma surgery. It involves not only removal of the diseased pleural lining but also the lung on the side where the mesothelioma tumor was located and the diaphragm on that side.

Extended pleurectomy/decortication (EPD) is almost as extensive, removing the pleura and a portion of the diaphragm, but leaving the lung in place. Both surgeries carry significant risks and lengthy recovery and are only performed in large medical centers by experienced surgeons.

A less extensive mesothelioma surgery option called pleurectomy/decortication (PD) does not involve the diaphragm.

The Role of the Diaphragm in Mesothelioma Recovery

Mesothelioma is an aggressive cancer that spreads easily and quickly within the chest and abdomen. The diaphragm is typically included in mesothelioma surgery in order to minimize the chance that new mesothelioma tumors could take hold there.

But the new report published in the European Journal of Cardiothoracic Surgery suggests that leaving the diaphragm intact – which can mean less trauma for the patient and a shorter, easier surgery – may be fine in some cases.

Of the 314 mesothelioma surgery patients they evaluated, almost 38 percent showed “no evidence of diaphragmatic involvement” when their tissue was examined by pathologists.

Just as importantly, the group found no evidence that the spread of mesothelioma to the diaphragm had an impact on overall mesothelioma survival after surgery.

“It may therefore theoretically be unnecessary to resect the diaphragm in all cases, and a pleurectomy-decortication could suffice,” writes surgeon and researcher Dr. Annabel J. Sharkey of University Hospitals Leicester.

Path to Survival Still Unclear

Unfortunately, the findings are not as clear cut as they might first appear.

Although many surgery patients had no mesothelioma cells on their diaphragms and although those who did did not necessary experience shorter survival, the researchers conceded that leaving the diaphragm in place could theoretically leave behind visible cells to regrow mesothelioma tumors, a situation known as an R2 resection.

“There is an unknown risk of R2 rection which would prejudice survival and as such we would advocate resecting the diaphragm in all cases to avoid an R2 resection,” concludes Dr. Sharkey.

But the study does leave the door open to different approaches. Because every case of mesothelioma is different, physicians and patients work together to develop the most appropriate surgical treatment plan for each situation.

Source:

Sharkey, AJ, et al, “The management of the diaphragm during radical surgery for malignant pleural mesothelioma”, March 22, 2016, “European Journal of Cardiothoracic Surgery, Epub ahead of print

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…